Private Advisor Group LLC decreased its holdings in Clorox Company (The) (NYSE:CLX) by 30.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,407 shares of the company’s stock after selling 10,744 shares during the quarter. Private Advisor Group LLC’s holdings in Clorox Company (The) were worth $3,258,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Ameriprise Financial Inc. grew its position in Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock worth $146,932,000 after buying an additional 25,110 shares during the last quarter. Geode Capital Management LLC grew its position in Clorox Company (The) by 4.3% in the first quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock worth $168,019,000 after buying an additional 51,563 shares during the last quarter. Destination Wealth Management grew its position in Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock worth $4,075,000 after buying an additional 3,716 shares during the last quarter. Advisors Asset Management Inc. grew its position in Clorox Company (The) by 16.2% in the first quarter. Advisors Asset Management Inc. now owns 62,403 shares of the company’s stock worth $8,414,000 after buying an additional 8,686 shares during the last quarter. Finally, Twin Tree Management LP acquired a new position in Clorox Company (The) in the first quarter worth approximately $1,686,000. Hedge funds and other institutional investors own 71.28% of the company’s stock.

Several research analysts have issued reports on the stock. Jefferies Group LLC restated a “hold” rating and issued a $137.00 price target (up previously from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. BidaskClub upgraded shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Barclays PLC restated an “equal weight” rating and issued a $136.00 price target (down previously from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BMO Capital Markets set a $150.00 price target on shares of Clorox Company (The) and gave the stock a “buy” rating in a research report on Thursday, August 3rd. Finally, Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target on the stock in a research report on Tuesday, July 4th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $129.05.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. Insiders sold 21,242 shares of company stock valued at $2,944,449 in the last ninety days. Insiders own 0.74% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/09/08/clorox-company-the-clx-shares-sold-by-private-advisor-group-llc.html.

Clorox Company (NYSE CLX) opened at 135.44 on Friday. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The firm has a market cap of $17.48 billion, a price-to-earnings ratio of 25.39 and a beta of 0.40. The company has a 50-day moving average of $135.49 and a 200-day moving average of $135.28.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter in the prior year, the firm earned $1.30 earnings per share. The business’s quarterly revenue was up 2.9% on a year-over-year basis. Analysts predict that Clorox Company will post $5.67 earnings per share for the current year.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.